Refractory Childhood Acute Lymphoblastic Leukemia
5 clinical trials · Condition
◉ Watch Refractory Childhood Acute Lymphoblastic Leukemia
| Record | Firm | Date |
|---|---|---|
| Ex Vivo Drug Sensitivity Testing and Mutation Profiling (NCT03860376) | Florida International University | 2019-02-21 |
| Nivolumab and Dasatinib in Treating Patients With Relapsed or Refractory Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (NCT02819804) | Northwestern University | 2017-08-17 |
| CD19 /22 CAR T Cells (AUTO3) for the Treatment of B Cell Acute Lymphoblastic Leukemia (ALL) (NCT03289455) | Autolus Limited | 2017-06-26 |
| Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children (NCT01858740) | Fred Hutchinson Cancer Center | 2014-04-10 |
Track Refractory Childhood Acute Lymphoblastic Leukemia automatically
Every clearance here is in the API, with alerts when new ones post.